BMS Anti-PD-1 preliminary data

› Forums › General Melanoma Community › BMS Anti-PD-1 preliminary data

  • Post
    • December 15, 2012 at 1:06 am
    POW
    Participant

       

      I found a Youtube video of Dr. Suzanne Topalian discussing the preliminary results of the Phase 1b clinical trial of BMS's anti-PD-1 antibody MDX-1106/BMS-936558  in June 2012.

      Basically, 70% of patients had adverse events, most common events (~50% of patients) were fatigue, rash, and diarrhea.

      For melanoma patients (n=96) 28% had either a partial or a complete response and an additional 6% had stable disease for at least 6 months. Of 31 patients that responded 20, were still responding after 1yr.

      View the entire presentation at 

       

      I found a Youtube video of Dr. Suzanne Topalian discussing the preliminary results of the Phase 1b clinical trial of BMS's anti-PD-1 antibody MDX-1106/BMS-936558  in June 2012.

      Basically, 70% of patients had adverse events, most common events (~50% of patients) were fatigue, rash, and diarrhea.

      For melanoma patients (n=96) 28% had either a partial or a complete response and an additional 6% had stable disease for at least 6 months. Of 31 patients that responded 20, were still responding after 1yr.

      View the entire presentation at 

      Topalian Youtube video ASCO meeting June 2012 http://www.youtube.com/watch?v=Ij_hq_52K7M

    Viewing 2 reply threads
    • Replies
    Viewing 2 reply threads
    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics